Vertex submits NDA For CF Drug, MacroGenics Reports ADC Prostate Cancer Trial Patient Deaths, FTC Extends Review Of Novo-Catalent Deal [The Good, The Bad, The Ugly] Off Script: A Pharma Manufacturing podcast

Artwork

Business News News Pharma Manufacturing

Indhold leveret af Pharma Manufacturing. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Pharma Manufacturing eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Off Script: A Pharma Manufacturing Podcast « »
Vertex submits NDA for CF drug, MacroGenics reports ADC prostate cancer trial patient deaths, FTC extends review of Novo-Catalent deal [The good, the bad, the ugly]

5M ago 4:14

Del

MP3•Episode hjem

Indhold leveret af Pharma Manufacturing. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Pharma Manufacturing eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:

The good — Vertex submits NDA for CF drug
The bad — MacroGenics reports patient deaths in prostate cancer ADC trial
The ugly — FTC extends review of Novo-Catalent deal

… continue reading

62 episoder

#Business News #News #Pharma Manufacturing

Artwork

Vertex submits NDA for CF drug, MacroGenics reports ADC prostate cancer trial patient deaths, FTC extends review of Novo-Catalent deal [The good, the bad, the ugly]

Off Script: A Pharma Manufacturing Podcast

published 5M ago

Del

MP3•Episode hjem

Indhold leveret af Pharma Manufacturing. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Pharma Manufacturing eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:

The good — Vertex submits NDA for CF drug
The bad — MacroGenics reports patient deaths in prostate cancer ADC trial
The ugly — FTC extends review of Novo-Catalent deal

… continue reading

62 episoder

#Business News #News #Pharma Manufacturing

すべてのエピソード

×

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

Lyt til 500+ emner